CAMP4 Therapeutics Corp. (CAMP)
4.45
-0.01
(-0.22%)
USD |
NASDAQ |
May 11, 16:00
4.45
0.00 (0.00%)
After-Hours: 16:28
CAMP4 Therapeutics Shareholders Equity (Quarterly) : 30.90M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Viridian Therapeutics, Inc. | 636.01M |
| Tyra Biosciences, Inc. | 259.18M |
| Entrada Therapeutics, Inc. | 270.85M |
| Fate Therapeutics, Inc. | 207.18M |
| Praxis Precision Medicines, Inc. | 1.410B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 105.46M |
| Total Liabilities (Quarterly) | 74.56M |
| Debt to Equity Ratio | 0.0687 |
| Current Ratio | 6.148 |
| Net Debt Paydown Yield | 0.58% |